F13.23
Sedative, hypnotic or anxiolytic dependence with withdrawal
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic use disorder, moderate
- Sedative, hypnotic, or anxiolytic use disorder, severe
Excludes Type 1
- sedative, hypnotic or anxiolytic dependence with intoxication (F13.22-)
Medical Intelligence & Overview
ICD-10 code F13.23 refers to a condition characterized by dependence on sedatives, hypnotics, or anxiolytics accompanied by withdrawal symptoms when not using these substances. These medications are often prescribed to treat anxiety, sleep disorders, or related conditions. However, prolonged or excessive use can lead to physical and psychological dependence, making cessation difficult and sometimes dangerous without proper medical support.
Causes & Symptoms
Clinical Causes: Long-term use of sedative, hypnotic, or anxiolytic medications as prescribed by healthcare providers Misuse or recreational use of these drugs Underlying mental health conditions such as anxiety or insomnia leading to continued medication use Lack of medical supervision during medication use or abrupt discontinuation Genetic predisposition to substance dependence
Key Symptoms: Craving or strong desire to use the medication Inability to reduce or control use despite wanting to do so Developing a tolerance, requiring increased doses for the same effect Withdrawal symptoms when not using the substance, such as anxiety, agitation, sweating, nausea, or tremors Neglecting responsibilities at work, home, or social activities due to drug use Persistent desire or unsuccessful efforts to stop or cut down medication use Using larger amounts or over a longer period than intended Continued use despite experiencing physical or psychological problems caused by the drug
Diagnostic & Treatment
Diagnosis Path: Diagnosis of sedative, hypnotic, or anxiolytic dependence with withdrawal involves a comprehensive evaluation by a healthcare professional. This includes a detailed medical history, assessment of medication usage patterns, physical examinations, and possibly laboratory tests. Healthcare providers look for signs of dependence, withdrawal symptoms, and its impact on daily life. Diagnostic criteria are based on recognized standards such as the DSM-5, which categorize substance use disorders by severity and characteristics.
Treatment Protocols: Supervised tapering of the medication to gradually reduce dependence while minimizing withdrawal symptoms Use of alternative medications or medications to manage specific withdrawal symptoms, under medical supervision Psychotherapy approaches such as cognitive-behavioral therapy (CBT) to address underlying issues and develop healthier coping mechanisms Support groups or counseling for ongoing support and relapse prevention Monitoring for potential complications or comorbid mental health issues Addressing any social or environmental factors contributing to substance dependence
Clinical Advice & FAQs
Billing Guidance
Is F13.23 a billable ICD-10 code?
Yes, F13.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.23?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with withdrawal and any associated comorbidities for accurate reporting.
Cite this Clinical Reference